An agreement has been reached over the sale of the maker French painkiller medicine, Doliprane (PRON: Dolly-prann) to a US investment fund.
The drug's owner, French pharmaceutical giant Sanofi, says its decision to offload its consumer drugs unit Opella is so it can focus more on research and development of vaccines.
Ross Cullen reports.
IN: "The french economy minister..."
OUT: SOC
DUR: 0:28